Alvine Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Alvine Pharmaceuticals Ownership

Who owns Alvine Pharmaceuticals?

Alvine Pharmaceuticals is owned by ImmunogenX. It was acquired on March 15, 2016.

Alvine Pharmaceuticals Business Overview

Where is Alvine Pharmaceuticals headquartered?

Alvine Pharmaceuticals is headquartered in San Carlos, California.

What sector is Alvine Pharmaceuticals in?

Alvine Pharmaceuticals is a life science company.

When was Alvine Pharmaceuticals founded?

Alvine Pharmaceuticals was founded in 2005.

Life Science M&A Summary in 2016

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Join Mergr to view all 293 acquisitions of life science companies in 2016, including 32 acquisitions by private equity firms, and 261 by strategics.

Alvine Pharmaceuticals, Inc.

75 Shoreway Road Suite B,
San Carlos, California 94070
United States,
(650) 596-2434
www.alvinepharma.com

Alvine Pharmaceuticals, Inc., is a privately held, clinical stage company developing biologics to target autoimmune/inflammatory diseases. Alvine’s lead product candidate, ALV003, is a mixture of two proteases engineered to degrade gluten. Gluten is the difficult to digest protein found in wheat, rye, and barley that triggers celiac disease in genetically susceptible individuals.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.